Tiagabine, a novel antiepileptic agent: Lack of pharmacokinetic interaction with digoxin

European Journal of Clinical Pharmacology

Volumn 54, Issue 4, 1998, Pages 355-357

  Snel, S ^a   Jansen, J A ^a   Pedersen, P C ^a   Jonkman, J H G ^b   Van Heiningen, P N M ^b  

^a NOVO NORDISK A S   (Denmark)

^b PRA International USA   (Netherlands)

Author keywords

Digoxin; Tiagabine

Indexed keywords

ANTICONVULSIVE AGENT; DIGOXIN; TIAGABINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG INTERACTION; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; STEADY STATE;

ADULT; ANTICONVULSANTS; CROSS-OVER STUDIES; DIGOXIN; DRUG INTERACTIONS; DRUG TOLERANCE; HUMANS; MALE; NIPECOTIC ACIDS;

EID: 0031819205     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050474     Document Type: Article

References (10)

1. Nielsen EB, Wolfbrandt KH, Anderson KE, Knutsen LJS, Sonneenwald U, Braestrup C (1987) NO-05-0325: a new potent GABA-uptake inhibitor. Soc Neurosci Abstr 13: 968
2. Brodie MJ (1995) Tiacabine pharmacology in profile. Epilepsia 36: S7-S9
3. Snel S, Mutkherjee S, Richens A, Mengel HB (1993) Pharmacokinetics of tiagabine in the elderly. Epilepsia 34: 157
4. Rodin SM, Johnson BF (1988) Pharmacokinetic interactions with digoxin. Clin Pharmacokinet 15: 227-244
5. International Conference on Harmonisation of Technical Requ for Human Use Guidelines: Studies in Support of Special Population
6. Bopp BA, Nequist GE, Rodrigues D (1995) Role of the cytochrome [14C] tiagabine by human hepatic microsomes. Epilepsia 36: S159
7. Gustavson LE, Chu SY (1989) High performance liquid chromatographic procedures for the determination of ABBOTT-70569 concentrations in biological fluids. Abbott Drug Metabolism Report No. 1, PPRd 89 223
8. Lehmann EL (1986) Testing statistical hypotheses. Wiley, New York
9. Gustavson LE, Mengel HB (1995) Pharmacokinetics of tiagabine, a γ-aminobutyric acid-uptake inhibitor in healthy subjects after single and multiple dosina. Epilepsia 36: 605-611
10. Leppik IE (1995) Tiagabine: the safety landscape. Epilepsia 36: S10-S13